Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGES2 | Q9H7Z7 | 11/20 | 0.58 |
| ▸ | PTGES | O14684 | 3/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.55 |
| ▸ | ALOX5AP | P20292 | 8/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23270776 | 1.00 | PTGES2 (0.58) | PTGES2PTGESPTGS1PTGS2ALOX5AP | |
| SCHEMBL9288153 | 0.91 | PTGES2 (0.60) | PTGES2PTGESPTGS1PTGS2ALOX5AP | |
| SCHEMBL23641032 | 0.91 | PTGES2 (0.60) | PTGES2PTGESPTGS1PTGS2ALOX5AP | |
| SCHEMBL25970457 | 0.86 | PTGES2 (0.51) | PTGES2PTGESPTGS1PTGS2ALOX5AP | |
| SCHEMBL23270745 | 0.85 | PTGES2 (0.80) | PTGES2PTGESPTGS1PTGS2ALOX5AP | |
| SCHEMBL23270813 | 0.83 | PTGES2 (0.62) | PTGES2PTGESPTGS1PTGS2ALOX5AP | |
| SCHEMBL30181343 | 0.83 | PTGES2 (0.62) | PTGES2PTGESPTGS1PTGS2ALOX5AP | |
| SCHEMBL23641194 | 0.82 | PTGES2 (0.58) | PTGES2PTGESPTGS1PTGS2ALOX5AP | |
| SCHEMBL25968363 | 0.82 | PTGES2 (0.64) | PTGES2PTGESPTGS1PTGS2ALOX5AP | |
| SCHEMBL30181215 | 0.81 | PTGES2 (0.73) | PTGES2PTGESPTGS1PTGS2ALOX5AP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240043423-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF HEDGEHOG PATHWAY ASSOCIATED CONDITIONS | SUZHOU MEDNES PHARMA TECH CO., LTD. (CN) | 2024-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240043423-A1 | COMPOUNDS AND METHODS FOR TREATMENT OF HEDGEHOG PATHWAY ASSOCIATED CONDITIONS | SHH, GLI1, SMO | PTGES2 1476/4885PTGES 1752/4885PTGS1 583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.